Treatment of patients with venous malformations of the maxillofacial region by sclerosing

Objective. To evaluate the efficacy of 3% sodium tetradecyl sulfate in the foam form in treating patients with venous malformations (VMs) of the maxillofacial region. Materials and methods. In total, 30 patients with VMs of the maxillofacial region were included in the study. The patients were divided into three groups: (1) patients with a small VM size of up to 2 cm in diameter; (2) patients with an average VM size from 2 to 6 cm in diameter; (3) patients with a large VM size above 6 cm in diameter. In the treatment of patients, a foam form of 3% sodium tetradecyl sulfate was used. Results. All patients were treated without intraoperative and postoperative bleeding. According to the results of the study, large VMs decreased in size by an average of 49.7%, medium malformations decreased by an average of 68.1%, while small malformations decreased by 69.6%. Conclusion. Sclerosing of venous malformations of the maxillofacial region with a foam form of 3% sodium tetradecyl sulfate is an effective, affordable, and safe treatment method.